Gut bacteria changes during short bowel syndrome recovery
Part of Digestive system clinical trials.
This study looks at how the natural bacteria in your gut (microbiota) affect how your intestine adapts after surgery for short bowel syndrome. It aims to understand this process to potentially improve treatments for people with this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You must have short bowel syndrome with a jejunostomy (a stoma from the small intestine) and a plan to reconnect the intestine to the colon within 3 months.
- Your remaining small intestine (after the ligament of Treitz) must be less than 200 cm (about 6.5 feet).
- More than 14% of your colon must be present.
- Your remaining intestine and colon must be healthy—no active inflammation, radiation damage, or poor blood flow.
- You must be covered by French social security or equivalent health insurance.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at short bowel syndrome in children who have had intestinal surgery. It may help doctors understand how to better treat this condition.
This study looks at how gut bacteria change after surgery to reconnect the intestines (anastomosis). It may help doctors understand complications and improve recovery.
This study tests if adding high-fiber foods can help people with short bowel syndrome (a condition where part of the small intestine is missing or removed). You will be asked to eat fiber-rich foods and the study team will see how your body handles them.
This study tests a new treatment called FT1 for people with short bowel syndrome. It aims to help you absorb more nutrients and fluids from food, potentially reducing the need for IV nutrition.
This study looks at how a specific gut bacterium, Pilosibacter rotomagensis, affects inflammation in the intestine after surgery for Crohn's disease. Understanding this may help guide future treatments.
This trial tests if crofelemer can reduce diarrhea and fluid loss in people with short bowel syndrome who have a stoma (no colon connection) and need intravenous nutrition or fluids. The goal is to see if it improves gut function and quality of life.
Hear when a new Short Bowel Syndrome (SBS) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.